NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $217,815 | +43.9% | 30,085 | +47.7% | 0.00% | 0.0% |
| Q2 2023 | $151,357 | -46.3% | 20,371 | -49.9% | 0.00% | 0.0% |
| Q1 2023 | $282,051 | -48.9% | 40,700 | -24.2% | 0.00% | -66.7% |
| Q4 2022 | $552,036 | -86.6% | 53,700 | -76.3% | 0.00% | -82.4% |
| Q3 2022 | $4,123,000 | -60.4% | 226,494 | +3.1% | 0.02% | -15.0% |
| Q2 2022 | $10,404,357 | -45.6% | 219,744 | -15.5% | 0.02% | -51.2% |
| Q1 2022 | $19,141,000 | -76.3% | 259,900 | -54.0% | 0.04% | -76.2% |
| Q4 2021 | $80,906,000 | +14.1% | 565,496 | +65.3% | 0.17% | +8.9% |
| Q3 2021 | $70,906,000 | -15.8% | 342,029 | -13.8% | 0.16% | -21.4% |
| Q2 2021 | $84,214,000 | – | 396,653 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 66,810 | $13,850,000 | 10.84% |
| Parametrica Management Ltd | 60,296 | $12,484,000 | 9.33% |
| RA Capital Management | 2,097,794 | $434,894,000 | 6.03% |
| Foresite Capital Management II, LLC | 67,373 | $13,967,000 | 4.96% |
| Samsara BioCapital, LLC | 82,600 | $17,124,000 | 2.69% |
| Rock Springs Capital Management LP | 455,000 | $94,326,000 | 1.98% |
| Tri Locum Partners LP | 19,300 | $4,001,000 | 1.59% |
| SECTORAL ASSET MANAGEMENT INC | 89,450 | $18,544,000 | 1.54% |
| Foresite Capital Management III, LLC | 5,000 | $1,037,000 | 1.44% |
| TSP Capital Management Group, LLC | 18,525 | $3,840,000 | 1.31% |